Topical Use of Cyclosporine in the Treatment of Vernal Keratoconjunctivitis-Reference-Cited by-同舟云学术

Topical Use of Cyclosporine in the Treatment of Vernal Keratoconjunctivitis

Published:1990-12 Issue:6 Volume:110 Page:641-645
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Secchi Antonio G.,Tognon M. Sofia,Leonardi Andrea

Publisher

Elsevier BV

Subject

Ophthalmology

Reference13 articles.

1. Cyclosporin A and dexamethasone suppress T-cell responses by selectively acting at distinct sites of the triggering mechanism;Larsson;J. Immunol.,1980

2. Effects of Cs-A in T-cell subsets in experimental autoimmune uveitis;Nussenblatt;Invest. Ophthalmol. Vis. Sci.,1985

3. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens;Lillehoj;J. Immunol.,1984

4. Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis;Chan;Invest. Ophthalmol. Vis. Sci.,1984

5. Modulation of experimental autoimmune uveitis with cyclosporin A;Nussenblatt;Arch. Ophthalmol.,1984

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis;The Ocular Surface;2024-10

2. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis;International Ophthalmology;2024-03-24

3. NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis;Clinical Therapeutics;2023-12

4. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape;Survey of Ophthalmology;2023-10

5. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021;Allergology International;2022-10